ANNAW
AleAnna, Inc. WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
-1.63
52W High
$1.28
52W Low
$0.12
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
23.80%
Forward P/E
—
PEG Ratio
—
About AleAnna, Inc. Warrant
AleAnna, Inc. Warrant (ANNAW) is an innovative biopharmaceutical company dedicated to developing transformative therapies for unmet medical needs. Leveraging cutting-edge technologies and a robust pipeline of unique drug candidates, AleAnna aims to improve patient outcomes and address significant health challenges. With collaborative partnerships across the healthcare landscape, the company positions itself for successful commercialization and scaling of its pioneering therapeutics, presenting a compelling growth opportunity for institutional investors in the dynamic biopharmaceutical sector.
Fundamentals
| Revenue (TTM) | $33.73M |
| Gross Profit (TTM) | $26.83M |
| EBITDA | $13.23M |
| Operating Margin | 33.00% |
| Return on Equity | 17.70% |
| Return on Assets | 6.62% |
| Revenue/Share (TTM) | $0.83 |
| Book Value | $0.90 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -97.10% |
| Quarterly Revenue Growth (YoY) | 1349.00% |
| Shares Outstanding | 0 |
| Float | $9.75M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
131.58%
HV 20-Day
134.51%
HV 30-Day
159.54%
HV 60-Day
135.67%
HV Rank
—
Volatility is currently contracting
Data last updated: 7/9/2026